IFT80 and Jeune syndrome: Our findings regarding the regulation of IFT80 in chondrocyte differentiation, cartilage formation, and Hh and Wnt signaling pathways, may open a new path to treat bone diseases including JATD, SRP, osteoarthritis by manipulating either IFT80 expression or related signaling pathways.